Medtech Acquisition Corp Stock Revenue
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
Medtech Acquisition Corp fundamentals help investors to digest information that contributes to Medtech Acquisition's financial success or failures. It also enables traders to predict the movement of Medtech Stock. The fundamental analysis module provides a way to measure Medtech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtech Acquisition stock.
Medtech |
Medtech Acquisition Corp Company Revenue Analysis
Medtech Acquisition's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Medtech Acquisition Corp reported 0.0 of revenue. This is 100.0% lower than that of the Capital Markets sector and about the same as Financials (which currently averages 0.0) industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Medtech Acquisition Corp is currently under evaluation in revenue category among its peers. Market size based on revenue of Financials industry is now estimated at about 0.0. Medtech Acquisition adds roughly 0.0 in revenue claiming only tiny portion of equities under Financials industry.Medtech Fundamentals
| Return On Asset | -0.0193 | |||
| Current Valuation | 81.09 M | |||
| Price To Earning | 39.61 X | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | 0.26 X | |||
| Beta | -0.0423 | |||
| Market Capitalization | 306.25 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 75.01 | |||
| Net Asset | 20.19 M |
About Medtech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtech Acquisition Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtech Acquisition Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |